News

News2019-05-29T14:36:04-04:00

Click here to view our newsroom page on the Newswise news-distribution service, for more information on our organization and a live stream of our Facebook and Twitter feeds.


 

[News Release] Clinical Research Pathways Taps Emory Physician for Board of Directors

May 29, 2019|Categories: News|

Dr. Derek West chosen for clinical research and mentoring experience

ATLANTA, May 30, 2019Clinical Research Pathways has appointed Dr. Derek West, cancer researcher and interventional radiologist, to its board of directors.

He joins six other directors, all chosen for their commitment to Clinical Research Pathways’ goals of increasing diversity in clinical research and expanding access to experimental drugs, biologics and medical devices.

West is an associate professor […]

[News Release] Clinical Research Pathways Names Two New Directors

February 25, 2019|Categories: News|

Attorney Keith Barnett and Rev. Dr. Jason E. Owen Join Nonprofit Board

ATLANTA, February 26, 2019 Clinical Research Pathways has appointed two new members to its board of directors: Attorney Keith Barnett, a partner in the national law firm Troutman Sanders, and Rev. Dr. Jason E. Owen, chief apostle and international presiding bishop of Biblical Deliverance Ministries.

[News Release] Morehouse School of Medicine Awarded $200,000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials

September 20, 2018|Categories: News|

Funded by Clinical Research Pathways, the New Program Intends to Fill a Gap in the Percentage of Minorities Who Participate in Clinical Trials

ATLANTA, September 20, 2018 — Morehouse School of Medicine (MSM) will launch a program specifically designed to increase the number of African American, Latino and other minority patients in clinical trials, in an effort that could eventually lead to the development of medical treatments better tailored for those […]

Seeking Physician Input on Using Expanded Access To Experimental Drugs for Their Patients

June 26, 2018|Categories: News|

*Update: This assessment is now closed. Click here to see the results.*

Clinical Research Pathways Needs Assessment Survey Aims to Assist Physicians

ATLANTA, Ga., June 26, 2018— Clinical Research Pathways has launched an effort to learn what information and other resources physicians need to seek access to experimental drugs for desperately ill or terminal patients, using the expanded access program.

Under the U.S. Food and Drug Administration’s […]

Clinical Research Pathways Names Two New Directors

June 5, 2018|Categories: News|

ATLANTA, Ga., June 5, 2018 — Clinical Research Pathways has appointed two new members to its board of directors: Anne B. Cropp of Early Access Care and Andrew McFadyen of The Isaac Foundation and Equal Access for Rare Disorders.

The former WCG Foundation, Clinical Research Pathways is a public charity that works to improve health and well-being for all by creating pathways to new medicines. The organization seeks to increase diversity in […]

WCG Foundation Is Now Clinical Research Pathways

May 22, 2018|Categories: News|

N E W S   R E L E A S E

FOR IMMEDIATE RELEASE                 

May 23, 2018

WCG Foundation Is Now Clinical Research Pathways

New name reflects focus on expanded access and inclusion in research.

ATLANTA, Ga., May 23, 2018—WCG Foundation is now Clinical Research Pathways, a name that better reflects the public charity’s emphasis on expanding patient and physician access to investigational drugs and promoting inclusion in clinical […]

Republicans Get Ready to Vote on “Right-to-Try” Bill Again

March 19, 2018|Categories: News|

Published March 19, 2018 by The American Journal of Managed Care

The right-to-try bill, which suffered a surprise 259-140 defeat in the House of Representatives last week, is scheduled for another vote this week, perhaps as early as Wednesday.

On Monday, the House Committee on Rules was scheduled to meet late in the day to change the procedure so that it could be passed with just a simple majority, rather than a […]

Weighing the Merits of Right-to-Try Laws and FDA’s Expanded Access Program

February 27, 2018|Categories: News|

Published February 27, 2018 by The American Journal of Managed Care

Just a month before attendees gathered in Philadelphia, Pennsylvania, for the annual meeting of Patient-Centered Oncology Care®, legislators in the state’s capital of Harrisburg made it the 38th to pass a right-to-try law. That was 6 states in 2017 alone.1 Championed by conservative groups like the Goldwater Institute as well as Vice President Mike Pence,2 the laws sound good on their […]

Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

January 9, 2018|Categories: News|

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF

ATLANTA, Ga., Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients.

The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?”—feature Richard Klein, former director of the Food and Drug […]

Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

January 9, 2018|Categories: News|

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF

ATLANTA, Ga.,  Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients.

The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?”—feature Richard Klein, former director of the Food and Drug […]

Load More Posts